Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Environmental Topics
Laws & Regulations
About EPA
Menu
Environmental Topics
Laws & Regulations
About EPA
Related Topics:
EPA National Library Network
Contact Us
Search Results for the EPA National Library Catalog
Items Found: 51
Showing: Items 1 - 50
Your Search: (SUBJECT=Pharmaceutical industry)
Sort Results:
Publication dates (newest-oldest)
Publication dates (oldest-newest)
Title
Choose a Library:
(CTRL-CLICK for multiple libraries)
Search all libraries
Capital Group(All DC-area libraries)
AWBERC Library/Cincinnati,OH
CCTE/GLTED Library/Duluth,MN
CEMM/ACESD Library/Narragansett,RI
CEMM/EPD Library/Athens,GA
CEMM/GEMMD Library/Gulf Breeze,FL
CPHEA/PESD Library/Corvallis,OR
Env Science Center Library/Ft Meade,MD
Headquarters Library/Washington,DC
Law Library/Washington,DC
NRMRL/GWERD Library/Ada,OK
NVFEL Library/Ann Arbor, MI
OCSPP Chemical Library/Washington,DC
Region 1 Library/Boston,MA
Region 2 Library/New York,NY
Region 3 Library/Philadelphia, PA
Region 4 Library/Atlanta,GA
Region 5 Library/Chicago,IL
Region 6 Library/Dallas,TX
Region 8 Technical Library/Denver,CO
Region 9 Library/San Francisco,CA
Region 10 Library/Seattle,WA
Research Triangle Park Library/RTP, NC
Choose a Collection:
(CTRL-CLICK for multiple collections)
Search all collections
books
documents
journals
reference
audiovisual
ebooks
1
2
NEXT
Select Item
Title
Year Published
1
American pharmaceutical review.
1998
2
Analytical methods for the determinatiion of pollutants in pharmaceutical manufacturing industry wastewater.
1998
3
Analytical methods for the determination of pollutants in pharmaceutical manufacturing industry wastewater.
1995
4
Biopharmaceuticals in transition
1990
5
Chemical industry
1994
6
Compliance Assistance Tool for CCA Regulations: Subpart GGG of 40 CFR Part 63 - NESHAPs for Source Category Pharmaceuticals Production.
2002
7
Compliance assistance tool for Clean Air Act regulations : subpart GGG of 40 CFR Part 63 NESHAPS for source category pharmaceutical production.
2002
8
Compliance assistance tool for pharmaceutical production, pesticide active ingredient production, and miscellaneous organic chemical manufacturing NESHAP : comparison of regulatory requirements and case study compliance illustrations for nondedicated equipment /
2004
9
Contractor's engineering report for the development of effluent limitations guidelines and standards for the pharmaceutical manufacturing industry point source category /
1980
10
Cost effectiveness analysis of effluent limitations and standards for the pharmaceutical industry /
1982
11
Cost effectiveness analysis of effluent standards and limitations for battery manufacturing /
1984
12
Cost-effectiveness analysis of final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry.
1998
13
Development document for effluent guidelines, new source performance standards and pretreatment standards for the pharmaceutical manufacturing point source category /
1982
14
Development document for effluent limitations quidelines and standards for the pharmaceutical manufacturing point source category /
1983
15
Development document for final best conventional technology effluent limitations guidelines for the pharmaceutical manufacturing point source catagory.
1986
16
Development document for final effluent limitations guidelines and standards for the pharmaceutical manufacturing point source category.
1998
17
Documentation basics : that support good manufacturing practices and quality system regulations /
2001
18
Drug manufacturing & supply.
2006
19
Drug repositioning : bringing new life to shelved assets and existing drugs /
2012
20
Drug truths : dispelling the myths about pharma R & D /
2009
21
Dun & Bradstreet/Gale Group industry handbook : chemicals and pharmaceuticals /
2000
22
Economic analysis of effluent standards and limitations for the pharmaceutical industry /
1983
23
Economic analysis of final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry.
1998
24
Economic analysis of interim final effluent guidelines for the pharmaceutical industry : group II.
1977
25
Economic analysis of proposed effluent standards and limitations for the pharmaceutical industry /
1982
26
Economic impact and regulatory flexibility analysis of proposed effluent guidelines for the pharmaceutical manufacturing industry : final report.
1995
27
Enhanced COD (Chemical Oxygen Demand) Removal from Pharmaceutical Wastewater Using Powdered Activated Carbon Addition to an Activated Sludge System.
1985
28
Environmental assessment of the final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry.
1998
29
Environmental assessment of the proposed effluent guidelines for the pharmaceutical manufacturing industry.
1995
30
EPA Office of Compliance Sector Notebook Project. Profile of the pharmaceutical manufacturing industry.
1997
31
EPA's 33/50 program company profile : Bristol-Myers Squibb Company.
1995
32
Evaluation of activated carbon for enhanced COD removal from pharmaceutical wastewater /
1985
33
Evaluation of activated carbon for enhanced COD removal from pharmaceutical wastewater : Volume 2. Appendices /
1985
34
Glocal pharma international brands and the imagination of local masculinity / [electronic resource] :
2016
35
Guides to pollution prevention : the pharmaceutical industry.
1991
36
Laboratory validation
2003
37
National emission standards for hazardous air pollutants (NESHAP) for the pharmaceutical manufacturing industry : background information for promulgated standards, summary of public comments and responses /
1998
38
OPD chemical buyers directory.
1969
39
Permit guidance document : pharmaceutical manufacturing point source category (40 CFR Part 439) /
2006
40
Pharmaceutical industry : hazardous waste generation, treatment, and disposal.
1976
41
Pharmaceutical Manufacturing Statutory and Regulatory Summaries.
1997
42
Pharmaceuticals manufacture
1991
43
Pollution prevention assessment for a manufacturer of pharmaceuticals /
1995
44
Preliminary data summary for the pharmaceutical manufacturing point source category.
1989
45
Product development planning for health care products regulated by the FDA
1997
46
Re-inventing drug development /
2015
47
Regulatory impact assessment of proposed effluent guidelines for the pharmaceutical manufacturing industry : final report.
1995
48
Statistical support document for final effluent limitations guidelines and standards for the pharmaceutical manufacturing industry.
1998
49
Volatile organic compound emission controls for tablet coating at pharmaceutical plants /
1984
50
Waste audit study, drug manufacturing and processing industry
1989
1
2
NEXT
Save, Print or Email Selected Records
Select Records
Selected (this page only)
Selected (across pages)
All (this page only)
All (all pages - 500 item maximum)
Select Format
Text (Brief Information)
Text (Full Information)
Endnote (Endnote Import)
ASCII delimited for EXCEL
Email Address:
(if applicable)